Suchergebnisse - "Hudson, Rachel"

PubPharm (19)

1

Hybrid speciation driven by multilocus introgression of ecological traits

enthalten in: Nature | 2024

von Rosser, N. | Seixas, F. | Queste, L. | +24

2

Drug exposure during pregnancy : Current understanding and approaches to measure maternal-fetal drug exposure

enthalten in: Frontiers in pharmacology | 2023

von Hudson, R. | Metz, T. | Ward, R. | +5

3

Improving Dose-Optimization Processes Used in Oncology Drug Development to Minimize Toxicity and Maximize Benefit to Patients

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2022

von Fourie Zirkelbach, J. | Shah, M. | Vallejo, J. | +12

4

Antibody-drug Conjugate PCMC1D3-Duocarmycin SA as a Novel Therapeutic Entity for Targeted Treatment of Cancers Aberrantly Expressing MET Receptor Tyrosine Kinase

enthalten in: Current cancer drug targets | 2022

von Hudson, R. | Yao, H. | Suthe, S. | +2

5

Examination of Complementary Medicine for Treating Urinary Tract Infections Among Pregnant Women and Children

enthalten in: Frontiers in pharmacology | 2022

von Hudson, R. | Job, K. | Sayre, C. | +3

6

Antibody-drug Conjugate PCMC1D3-Duocarmycin SA as a Novel Therapeutic Entity for Targeted Treatment of Cancers Aberrantly Expressing MET Receptor Tyrosine Kinase

enthalten in: Current cancer drug targets | 2022

von Hudson, R. | Yao, H. | Suthe, S. | +2

7

Duocarmycin-based antibody-drug conjugates as an emerging biotherapeutic entity for targeted cancer therapy : Pharmaceutical strategy and clinical progress

enthalten in: Drug discovery today | 2021

von Yao, H. | Zhao, H. | Hudson, R. | +2

8

Progress and challenge in development of biotherapeutics targeting MET receptor for treatment of advanced cancer

enthalten in: Biochimica et biophysica acta. Reviews on cancer | 2020

von Yao, H. | Hudson, R. | Wang, M.

9

MET and RON receptor tyrosine kinases in colorectal adenocarcinoma : molecular features as drug targets and antibody-drug conjugates for therapy

enthalten in: Journal of experimental & clinical cancer research : CR | 2020

von Yao, H. | Tong, X. | Hudson, R. | +1

10

MET and RON receptor tyrosine kinases in colorectal adenocarcinoma: molecular features as drug targets and antibody-drug conjugates for therapy

enthalten in: Journal of experimental & clinical cancer research | 2020

von Yao, H. | Tong, X. | Hudson, R. | +1